Correction: A novel oncolytic Vaccinia virus armed with IL-12 augments antitumor immune responses leading to durable regression in murine models of lung cancer

Frontiers in Immunology 2026 Open access

Read full text
Authors: Lijuan Chen, Pengju Wang, Carmela Di Gioia, Ming Yuan, Zhe Zhang, Jinxin Miao, Wenli Yan, Guanghao Zhao, Yangyang Jia, Na Wang, Zhongxian Zhang, Haoran Guo
+4 more Giulia Marelli, Louisa Chard Dunmall, Nicholas Robert Lemoine, Yaohe Wang
DOI: 10.3389/fimmu.2026.1812288
Cited by: 0

Abstract

[This corrects the article DOI: 10.3389/fimmu.2024.1492464.].

Fields of Study & Subjects

Virus-based gene therapy research Immunotherapy and Immune Responses Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
Frontiers in Immunology
Volume
17
Pages
1812288–1812288
Publication date
4 March 2026
Language
EN